Altimmune to report second quarter 2024 financial results and provide business update on august 8, 2024

Gaithersburg, md., aug. 01, 2024 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2024 financial results on thursday, august 8, 2024 and will provide a business update.

ALT Ratings Summary

ALT Quant Ranking